DSpace Repository

Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients

Show simple item record

dc.contributor.author Bayramoglu, Adil
dc.contributor.author Bektas, Osman
dc.contributor.author Gunaydin, Zeki Yuksel
dc.contributor.author Kaya, Ahmet
dc.contributor.author Oduncu, Vecih
dc.contributor.author Tanboga, Ibrahim Halil
dc.contributor.author Tasolar, Hakan
dc.contributor.author Yaman, Mehmet
dc.date.accessioned 2022-08-17T05:25:45Z
dc.date.available 2022-08-17T05:25:45Z
dc.date.issued 2018
dc.identifier.uri http://doi.org/10.1111/joic.12463
dc.identifier.uri http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2277
dc.description.abstract BackgroundNo-reflow is associated with a poor prognosis in STEMI patients. There are many factors and mechanisms that contribute to the development of no-reflow, including age, reperfusion time, a high thrombus burden, Killip class, long stent use, ejection fraction 40, and a high Syntax score. In this study, we aimed to evaluate the parameters associated with no-reflow prediction by creating a new scoring system. MethodsThe study included 515 consecutive STEMI patients who underwent PCI; 632 STEMI patients who had undergone PCI in another center were included in the external validation of the scoring system. The correlations between 1-year major adverse cardiac events and low/high risk score were assessed. ResultsIn this study, seven independent variables were used to build a risk score for predicting no-reflow. The predictors of no-reflow are age, EF 40, SS 22, stent length 20, thrombus grade 4, Killip class 3, and pain-balloon time 4h. In the derivation group, the optimal threshold score for predicting no-reflow was >10, with a 75% sensitivity and 77.7% specificity (Area under the curve (AUC)=0.809, 95%CI: 0.772-0.842, P<0.001). In the validation group, AUC was 0.793 (95%CI: 0.760-0.824, P<0.001). ConclusionThis new score, which can be calculated in STEMI patients before PCI and used to predict no-reflow in STEMI patients, may help physicians to estimate the development of no-reflow in the pre-PCI period. en_US
dc.language.iso eng en_US
dc.publisher WILEY-HINDAWI, ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND en_US
dc.relation.isversionof 10.1111/joic.12463 en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject new scoring system; no-reflow; ST segment elevation myocardial infarction en_US
dc.title Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients en_US
dc.type article en_US
dc.relation.journal JOURNAL OF INTERVENTIONAL CARDIOLOGY en_US
dc.contributor.department Ordu Üniversitesi en_US
dc.contributor.authorID 0000-0002-6523-9130 en_US
dc.identifier.volume 31 en_US
dc.identifier.issue 2 en_US
dc.identifier.startpage 144 en_US
dc.identifier.endpage 149 en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account